Integrated genomic analyses of ovarian carcinoma Cancer Genome Atlas Research Network Nature 474 (7353), 609, 2011 | 6814 | 2011 |
Integrated genomic characterization of endometrial carcinoma DA Levine, ... Nature 497 (7447), 67-73, 2013 | 4812 | 2013 |
ARID1A mutations in endometriosis-associated ovarian carcinomas KC Wiegand, SP Shah, OM Al-Agha, Y Zhao, K Tse, T Zeng, J Senz, ... New England Journal of Medicine 363 (16), 1532-1543, 2010 | 1898 | 2010 |
Ovarian carcinoma subtypes are different diseases: implications for biomarker studies M Köbel, SE Kalloger, N Boyd, S McKinney, E Mehl, C Palmer, S Leung, ... PLoS medicine 5 (12), e232, 2008 | 955 | 2008 |
Mutation of FOXL2 in granulosa-cell tumors of the ovary SP Shah, M Köbel, J Senz, RD Morin, BA Clarke, KC Wiegand, G Leung, ... New England Journal of Medicine 360 (26), 2719-2729, 2009 | 854 | 2009 |
Ductal pancreatic cancer modeling and drug screening using human pluripotent stem cell–and patient-derived tumor organoids L Huang, A Holtzinger, I Jagan, M BeGora, I Lohse, N Ngai, C Nostro, ... Nature medicine 21 (11), 1364-1371, 2015 | 716 | 2015 |
Recurrent somatic DICER1 mutations in nonepithelial ovarian cancers A Heravi-Moussavi, MS Anglesio, SWG Cheng, J Senz, W Yang, ... New England Journal of Medicine 366 (3), 234-242, 2012 | 506 | 2012 |
Distinct evolutionary trajectories of primary high‐grade serous ovarian cancers revealed through spatial mutational profiling A Bashashati, G Ha, A Tone, J Ding, LM Prentice, A Roth, J Rosner, ... The Journal of pathology 231 (1), 21-34, 2013 | 490 | 2013 |
Systematic analysis of immune infiltrates in high-grade serous ovarian cancer reveals CD20, FoxP3 and TIA-1 as positive prognostic factors K Milne, M Köbel, SE Kalloger, RO Barnes, D Gao, CB Gilks, PH Watson, ... PloS one 4 (7), e6412, 2009 | 455 | 2009 |
Differences in tumor type in low-stage versus high-stage ovarian carcinomas M Köbel, SE Kalloger, DG Huntsman, JL Santos, KD Swenerton, ... International Journal of Gynecological Pathology 29 (3), 203-211, 2010 | 409 | 2010 |
Amplification of PVT1 contributes to the pathophysiology of ovarian and breast cancer Y Guan, WL Kuo, JL Stilwell, H Takano, AV Lapuk, J Fridlyand, JH Mao, ... Clinical cancer research 13 (19), 5745-5755, 2007 | 409 | 2007 |
Ovarian carcinomas with genetic and epigenetic BRCA1 loss have distinct molecular abnormalities JZ Press, A De Luca, N Boyd, S Young, A Troussard, Y Ridge, P Kaurah, ... BMC cancer 8, 1-12, 2008 | 361 | 2008 |
Divergent modes of clonal spread and intraperitoneal mixing in high-grade serous ovarian cancer A McPherson, A Roth, E Laks, T Masud, A Bashashati, AW Zhang, G Ha, ... Nature genetics 48 (7), 758-767, 2016 | 340 | 2016 |
Intraepithelial T cells and prognosis in ovarian carcinoma: novel associations with stage, tumor type, and BRCA1 loss B Clarke, AV Tinker, CH Lee, S Subramanian, M Van De Rijn, D Turbin, ... Modern Pathology 22 (3), 393-402, 2009 | 332 | 2009 |
Type-specific cell line models for type-specific ovarian cancer research MS Anglesio, KC Wiegand, N Melnyk, C Chow, C Salamanca, ... PloS one 8 (9), e72162, 2013 | 295 | 2013 |
Quantitative assessment of airway remodeling using high-resolution CT Y Nakano, NL Müller, GG King, A Niimi, SE Kalloger, M Mishima, PD Paré Chest 122 (6), 271S-275S, 2002 | 282 | 2002 |
Loss of BAF250a (ARID1A) is frequent in high‐grade endometrial carcinomas KC Wiegand, AF Lee, OM Al‐Agha, C Chow, SE Kalloger, DW Scott, ... The Journal of pathology 224 (3), 328-333, 2011 | 273 | 2011 |
Tumor cell type can be reproducibly diagnosed and is of independent prognostic significance in patients with maximally debulked ovarian carcinoma CB Gilks, DN Ionescu, SE Kalloger, M Köbel, J Irving, B Clarke, J Santos, ... Human pathology 39 (8), 1239-1251, 2008 | 271 | 2008 |
IL6-STAT3-HIF signaling and therapeutic response to the angiogenesis inhibitor sunitinib in ovarian clear cell cancer MS Anglesio, J George, H Kulbe, M Friedlander, D Rischin, C Lemech, ... Clinical cancer research 17 (8), 2538-2548, 2011 | 265 | 2011 |
A limited panel of immunomarkers can reliably distinguish between clear cell and high-grade serous carcinoma of the ovary M Köbel, SE Kalloger, J Carrick, D Huntsman, H Asad, E Oliva, ... The American journal of surgical pathology 33 (1), 14-21, 2009 | 251 | 2009 |